Differing actions of the acute administration of propranolol and isosorbide-5-mononitrate on the portal circulation

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 5, 1996, Pages 795-800

  Forrest, E H ^a   Jalan, R ^a   Redhead, D N ^a   Hayes, P C ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISOSORBIDE 5 NITRATE; PROPRANOLOL;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; FEMALE; HEMODYNAMICS; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PORTAL HYPERTENSION; PORTAL VEIN BLOOD FLOW; PORTOSYSTEMIC ANASTOMOSIS; PRESSORECEPTOR; PRIORITY JOURNAL; THERMODILUTION;

EID: 0029799908     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1996.62204000.x     Document Type: Article

References (29)

1. Burroughs A, d'Hygere F, McIntyre N. Pitfalls in studies of prophylactic therapy for variceal bleeding in cirrhosis. Hepatology 1986; 6: 1407-13.
2. Fleig WE, Stange EF. Esophageal varices. Endoscopy 1989; 21: 86-96.
3. Reichen J. Liver function and pharmacological considerations in pathogenesis and treatment of portal hypertension. Hepatology 1990; 11: 1066-78.
4. Grose RD, Hayes PC. The pathophysiology and pharmacological treatment of portal hypertension. Aliment Pharmacol Ther 1992; 6: 521-40.
5. Kroeger RJ, Groszmann RJ. Increased portal venous resistance hinders portal pressure reduction during the administration of beta-adrenergic blocking agents in a portal hypertensive model. Hepatology 1985; 1: 97-101.
6. Pizcueta MP, de Lacy AM, Kravetz D, et al. Propranolol decreases portal pressure without changing portocollateral resistance in cirrhotic rats. Hepatology 1989; 6: 953-7.
7. Garcia-Pagan JC, Feu F, Bosch J, Rodes J. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. Ann Intern Med 1991; 114: 869-73.
8. Grose RD, Plevris JN, Redhead DN, Bouchier IAD, Hayes PC. The acute and chronic effects of isosorbide-5-mononitrate on portal haemodynamics in cirrhosis. J Hepatol 1994; 20: 542-7.
9. Jones AL, Hayes PC. Organic nitrates in portal hypertension. Am J Gastroenterol 1994; 89: 7-14.
10. Forrest EH, Jalan R, Redhead D, Hayes PC. Direct continuous measurement of portal vein flow in patients with TIPSS - a new model for therapeutic studies. Gut 1994; 35(Suppl. 5): S23 (Abstract).
11. Feu F, Garcia-Pagan JC, Luca A, et al. Impact of TIPS on hepatic hemodynamics and liver function in patients with cirrhosis. J Hepatol 1994; 21(Suppl. 1): S47 (Abstract).
12. Nunez M, Sangro B, Ouiroga J, et al. Exacerbation of the hyperdynamic systemic circulation and changes in vasoactive neurohumoral systems after TIPS in cirrhotic patients. J Hepatol 1994; 21(Suppl. 1): S131 (Abstract).
13. Hayes P, Terrace D, Peaston I, et al. A computerised system for the continuous measurement of azygos blood flow. Gut 1992; 33: 372-4.
14. Zoli M, Magalotti D, Bianchi G, et al. Functional hepatic flow and doppler-assessed total hepatic flow in control subjects and patients with cirrhosis. J Hepatol 1995; 23: 129-34.
15. Sabra C, Weltin GC, Cicchetti DV, et al. Observer variability in echo-doppler measurements of portal vein flow in cirrhotic patients and normal volunteers. Gastroenterology 1990; 98: 1603-11.
16. Sabra C, Merkel C, Zoli M, et al. Interobserver and interequipment doppler examination of the portal vein: effect of a cooperative training program. Hepatology 1995; 21: 428-33.
17. Biber B, Holm C, Winso O, Gustavsson B. Portal blood flow in man during surgery, measured by a modification of the continuous thermodilution method. Scand J Gastroenterol 1983; 18: 233-9.
18. Azoulay D, Castaing D, Dennison A, Martino W, Eyraud D, Bismouth H. Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective study. Hepatology 1994; 19: 129-32.
19. Lebrec D, Hillon P, Munoz C, et al. The effects of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study. Hepatology 1982; 2: 523-7.
20. Braillon A, Jiron MI, Valla D, et al. Effect of propranolol on hepatic blood flow in patients with cirrhosis. Clin Pharmacol Ther 1985; 37: 376-80.
21. Mastai R, Bosch J, Bruix J, et al. Beta-blockade with propranolol and hepatic artery blood flow in patients with cirrhosis. Hepatology 1989; 3: 269-72.
22. Marteau P, Ballet F, Chazouilleres O, et al. Effect of vasodilators on hepatic microcirculation in cirrhosis: a study in the isolated perfused rat liver. Hepatology 1989; 6: 820-3.
23. Bhathal PS, Grossman HJ. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators. J Hepatol 1985; 1: 325-37.
24. Hayes PC, Westaby D, Wiliams R. Effect and mechanism of action of isosorbide-5-mononitrate. Gut 1988; 29: 752-5.
25. Navasa M, Chesta J, Bosch J, Rodes J. Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Gastroenterology 1989; 96: 1110-8.
26. 6 Um S, Nishida O, Tokubayashi M, et al. Haemodynamic changes after ligation of a major branch of the portal vein in rats: comparison with rats with portal vein constriction. Hepatology 1994; 19: 202-9.
27. Garcia-Pagan JC, Navasa M, Bosch J, et al. Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis. Hepatology 1990; 11: 230-8.
28. Gilmore GT, Henderson JM, MacKay G, Galloway JR. The effect of propranolol on portal perfusion in patients with alcoholic cirrhosis having distal splenorenal shunts. J Hepatol 1994; 20: 2-10.
29. Brensing KA, Raab P, Textor J, et al. Hemodynamic response of the portal and systemic circulation to nitrate and propranolol in patients with liver cirrhosis and an intrahepatic portosystemic stent shunt. Gastroenterology 1995; 108: A1040(Abstract).